Evaluation of TDP-43 and Behavior in a Mouse Model of C9ORF72
Author Information
Author(s): Emily G. Thompson, Olivia Spead, S. Can Akerman, Carrie Curcio, Benjamin L. Zaepfel, Erica R. Kent, Thomas Philips, Balaji G. Vijayakumar, Anna Zacco, Weibo Zhou, Guhan Nagappan, Jeffrey D. Rothstein
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
The AAV-(G4C2)66 mouse model will exhibit key molecular and behavioral characteristics associated with C9-ALS.
Conclusion
The AAV-(G4C2)66 mouse model shows significant RNA and dipeptide repeat pathology but lacks evidence of TDP-43 dysfunction and clinical impairment.
Supporting Evidence
- The model displays key molecular ALS pathological markers including RNA foci and dipeptide repeat protein aggregation.
- Despite the presence of these markers, there is negligible neuronal loss or clinical deficits.
- The study highlights the complexity of ALS pathogenesis and the need for more comprehensive model systems.
Takeaway
Researchers created a special mouse model to study a genetic cause of ALS, but found that while the model shows some disease signs, it doesn't show all the expected problems.
Methodology
The study involved randomization, blinding, and power analysis to assess the effects of the AAV-(G4C2)66 model on behavior and pathology.
Potential Biases
Potential biases may arise from the randomization and blinding processes, though they were implemented to minimize such risks.
Limitations
The model does not exhibit significant neurodegeneration or TDP-43 dysfunction, limiting its use for studying these aspects of ALS.
Participant Demographics
C57BL/6J mice, both male and female, were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website